Pyrogen Testing Market to expand at a CAGR of 11% by 2024

Posted by Vikas Bahurupi on June 12th, 2018

According to a report published by Research Report Insights, the global market for pyrogen testing is anticipated to expand at 11% CAGR over the forecast period (2016-2024). In 2015, the market was valued at US$ 538.8 million, which is expected to reach US$ 1.37 billion by 2024 end.

Pyrogens prompts body temperature when administered into the body. Increasing prevalence of lifestyle and chronic diseases is one of the major factors influencing the demand for pyrogens testing. In addition, growing number of biotech and pharmaceutical companies coupled with increasing awareness on healthcare and higher emphasis on prevention and treatment of chronic diseases at initial stage is expected to drive the global market of pyrogen testing Market.

Report For Report Sample with Table of Contents@https://www.researchreportinsights.com/report/sample/110114676/Pyrogen-Testing-Market

The global market for pyrogens testing is classified into application, test type, end users, and regions.

On the basis of application, the market is segmented into injections, tablets, vaccines, and medical devices. Tablets segment is expected to be the dominant segment in 2016 owing to the higher focus on improving the quality of drugs. On the other hand, the injection segment is expected to register the fastest growth rate during the forecast period. This is due to increasing prevalence of chronic disease and growing awareness on healthcare across the globe. 

By test type, the market is segmented into rabbit pyrogen test, recombinant factor C assay, monocyte activation assay (MAT) and limulus amebocyte lysate (LAL). Limulus amebocyte lysate will be the largest segment of the market in 2016. Demand for this segment is largely attributed to the increasing inclination towards animal-free detection. The segment is anticipated to expand at over 11% CAGR through 2024. Moreover, LAL is the preferred test type for detecting endotoxins in pharmaceuticals and surgical implants. However, monocyte activation assay (MAT) is expected to witness a higher growth rate, registering a 14.7% CAGR during the forecast period.

Request For Report Discount@ https://www.researchreportinsights.com/report/discount/110114676/Pyrogen-Testing-Market

Growing number of pharmaceutical companies expected to support the global pyrogen testing market over 2016-2024

By end users, the market is segmented into biotechnology industry, pharmaceutical industry, and medical devices industry. In 2016, pharmaceutical industry will remain the largest segment of the market owing to its increasing preference for pyrogen testing of products to detect endotoxin elements in them. The biotechnology industry is another segment that is expected to grow at a healthy pace, registering a 12.1% CAGR, which is the highest amongst all the other end user segment.